| P50 | author | Wanda Baer-Dubowska | Q42729588 |
| | Krzysztof Kus | Q55456569 |
| | Elżbieta Nowakowska | Q55456572 |
| P2093 | author name string | Michał Cichocki | |
| | Anna Czubak | |
| | Kinga Burda | |
| | Jana Metelska | |
| P2860 | cites work | Serotonin model of schizophrenia: emerging role of glutamate mechanisms | Q28138722 |
| | A neurotrophic model for stress-related mood disorders | Q29616291 |
| | Neurotrophins and synaptic plasticity | Q33593433 |
| | BDNF and activity-dependent synaptic modulation | Q33820669 |
| | Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus | Q33925002 |
| | Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor | Q33932396 |
| | A molecular and cellular theory of depression | Q34064955 |
| | Studies in animal models and humans suggesting a role of nerve growth factor in schizophrenia-like disorders. | Q34096949 |
| | Neurotrophins as synaptic modulators | Q34186265 |
| | Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants | Q34211475 |
| | Role for brain-derived neurotrophic factor in learning and memory | Q34521554 |
| | From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning | Q34931098 |
| | Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia | Q35618342 |
| | Neurotrophins and neuronal plasticity | Q40418979 |
| | Neurotrophic factors and synaptic plasticity | Q40423304 |
| | Cortical degeneration in the absence of neurotrophin signaling: dendritic retraction and neuronal loss after removal of the receptor TrkB. | Q41734248 |
| | Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. | Q42556936 |
| | BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs | Q43698142 |
| | Cholinergic regulation of hippocampal brain-derived neurotrophic factor mRNA expression: evidence from lesion and chronic cholinergic drug treatment studies | Q44219936 |
| | Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs | Q44246562 |
| | Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus | Q44259220 |
| | Bi-phasic change in BDNF gene expression following antidepressant drug treatment | Q44426462 |
| | Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia | Q44507092 |
| | Olanzapine counteracts reduction of brain-derived neurotrophic factor and TrkB receptors in rat hippocampus produced by haloperidol | Q44744729 |
| | Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity | Q45108268 |
| | BDNF level in the rat prefrontal cortex increases following chronic but not acute treatment with duloxetine, a dual acting inhibitor of noradrenaline and serotonin re-uptake | Q46825159 |
| | Enhanced BDNF signaling is associated with an antidepressant-like behavioral response and changes in brain monoamines | Q46878695 |
| | Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus | Q46916229 |
| | Learning upregulates brain-derived neurotrophic factor messenger ribonucleic acid: a mechanism to facilitate encoding and circuit maintenance? | Q46919268 |
| | Positive feedback between acetylcholine and the neurotrophins nerve growth factor and brain-derived neurotrophic factor in the rat hippocampus | Q48149280 |
| | Requirement for BDNF in activity-dependent survival of cortical neurons | Q48156100 |
| | Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains | Q48225092 |
| | Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein | Q48258812 |
| | Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. | Q48273556 |
| | Alpha-bungarotoxin binding to hippocampal interneurons: immunocytochemical characterization and effects on growth factor expression. | Q48291215 |
| | Neurotrophin trafficking by anterograde transport | Q48368279 |
| | Neurotrophic factors and the maldevelopmental hypothesis of schizophrenic psychoses. Review article | Q48468948 |
| | Rapid and selective induction of BDNF expression in the hippocampus during contextual learning | Q48563557 |
| | Behavioural and biochemical adaptations to nicotine in rats: influence of MK801, an NMDA receptor antagonist | Q48586006 |
| | Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus | Q48623854 |
| | Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. | Q48635095 |
| | Decreased serum brain-derived neurotrophic factor levels in major depressed patients | Q48642995 |
| | 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. | Q48728233 |
| | Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). | Q48824073 |
| | Prenatal exposure to methylazoxymethanol acetate in the rat alters neurotrophin levels and behavior: considerations for neurodevelopmental diseases | Q49122714 |
| | The influence of tobacco smoke and nicotine on antidepressant and memory-improving effects of venlafaxine. | Q51203746 |
| | Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. | Q52012874 |
| | Involvement of brain-derived neurotrophic factor in spatial memory formation and maintenance in a radial arm maze test in rats. | Q52024403 |
| | Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. | Q52201421 |
| | Neuronal plasticity and survival in mood disorders. | Q52541461 |
| | Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients | Q73978751 |
| | Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication | Q74424004 |
| P433 | issue | 6 | |
| P921 | main subject | nicotine | Q12144 |
| P304 | page(s) | 1017-1023 | |
| P577 | publication date | 2009-11-01 | |
| P1433 | published in | Pharmacological Reports | Q15766499 |
| P1476 | title | Influences of chronic venlafaxine, olanzapine and nicotine on the hippocampal and cortical concentrations of brain-derived neurotrophic factor (BDNF) | |
| P478 | volume | 61 | |